Hall Laurie J Trustee Alnylam Pharmaceuticals, Inc. Transaction History
Hall Laurie J Trustee
- $316 Million
- Q3 2024
A detailed history of Hall Laurie J Trustee transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Hall Laurie J Trustee holds 3,250 shares of ALNY stock, worth $877,337. This represents 0.28% of its overall portfolio holdings.
Number of Shares
3,250
Previous 3,250
-0.0%
Holding current value
$877,337
Previous $790,000
13.16%
% of portfolio
0.28%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
638Shares Held
108MCall Options Held
2.33MPut Options Held
2.15M-
Capital World Investors Los Angeles, CA15MShares$4.04 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.38 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.58 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.68 Billion0.28% of portfolio
-
Baillie Gifford & CO6.03MShares$1.63 Billion1.16% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.2B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...